Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline Augmentation for Smoking Cessation in Heavy Drinkers
NCT02859142Phase 4Completed
- Sponsor
- University of Chicago
- Start
- Mar 2018
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of varenicline in Tobacco Use Disorder (TUD), sponsored by University of Chicago. Started Mar 2018; status: completed.
02
Drugs
varenicline
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02859142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02859142.